GOVX-B11

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameGOVX-B11
Drug Alias NameGEO-D03 DNA vaccine,GeoVax Clade B DNA/MVA HIV/AIDS VaccinepGA2-JS7 + MVA/HIV62MVA-HIV62BGOVX-B11 +[6] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine > Viral vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPeru
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmory UniversityGeovax Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoGeovax Inc
Inactive CompaniesGeovax Labs IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsAcquired Immunodeficiency Syndrome
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A